Human Metabolome Technologies, Inc. provided consolidated earnings guidance for the fiscal year ending June 2023. For the year, the company expects net sales of JPY 1,300 million, operating profit of JPY 240 million, profit attributable to owners of parent JPY 270 million and basic earnings per share of JPY 45.76.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
651 JPY | -1.66% | -0.15% | +1.72% |
1st Jan change | Capi. | |
---|---|---|
+1.72% | 25.09M | |
+40.12% | 54.04B | |
+45.38% | 41.96B | |
-1.39% | 41.92B | |
-7.20% | 28.35B | |
+12.49% | 26.35B | |
-21.17% | 19B | |
+6.97% | 13B | |
+28.79% | 12.28B | |
+25.95% | 12.19B |
- Stock Market
- Equities
- 6090 Stock
- News Human Metabolome Technologies, Inc.
- Human Metabolome Technologies, Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending June 2023